US Stock MarketDetailed Quotes

SHPH Shuttle Pharmaceuticals

Watchlist
  • 0.774
  • +0.003+0.38%
Trading Dec 26 15:05 ET
2.84MMarket Cap-0.18P/E (TTM)

Shuttle Pharmaceuticals Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
90.82%3.05M
1.16%1.48M
-10.35%1.38M
151.40%5.89M
141.89%1.28M
94.67%1.6M
314.46%1.47M
141.98%1.54M
34.47%2.34M
-46.35%530.34K
Selling and administrative expenses
198.03%1.65M
33.70%836.92K
28.21%798.74K
83.22%2.38M
7.64%572.38K
263.43%553.97K
132.05%625.97K
81.90%622.98K
79.77%1.3M
-2.68%531.77K
-General and administrative expense
198.03%1.65M
33.70%836.92K
28.21%798.74K
83.22%2.38M
7.64%572.38K
263.43%553.97K
132.05%625.97K
81.90%622.98K
79.77%1.3M
-2.68%531.77K
Research and development costs
34.00%1.4M
-23.10%645.72K
-36.42%586.1K
235.80%3.52M
49,574.16%710.45K
56.22%1.05M
901.17%839.67K
211.51%921.8K
2.50%1.05M
-100.32%-1.44K
Operating profit
-90.82%-3.05M
-1.16%-1.48M
10.35%-1.38M
-151.40%-5.89M
-141.89%-1.28M
-94.67%-1.6M
-314.46%-1.47M
-141.98%-1.54M
-34.47%-2.34M
46.35%-530.34K
Net non-operating interest income expense
55.18%-270.15K
41.55%-416.53K
31.12%-476.06K
-275.20%-2.52M
-276.25%-509.65K
2.55%-602.7K
-284.76%-712.67K
-342.75%-691.13K
-1,220.41%-670.61K
1,647.62%289.16K
Non-operating interest income
-87.84%2.52K
-26.52%14.16K
28.55%21.45K
--79.12K
--22.4K
--20.77K
--19.27K
--16.69K
--0
--0
Non-operating interest expense
-56.26%272.68K
-41.16%430.69K
-17.57%497.52K
418.21%2.49M
211.06%532.05K
0.81%623.47K
295.16%731.94K
286.65%603.57K
846.48%480.7K
-2,664.07%-479.07K
Total other finance cost
----
----
----
-45.11%104.25K
--0
----
----
--104.25K
--189.91K
----
Other net income (expense)
-213.02%-462.37K
-2,076.24%-132.05K
-89.70%129.88K
191.63%1.82M
106.13%151.97K
-7.34%409.09K
89.61%-6.07K
1,019.16%1.26M
-408.84%-1.98M
-551.93%-2.48M
Gain on sale of security
-33.74%299.82K
-132.25%-132.05K
-84.27%201.19K
490.19%2.29M
122.29%151.97K
301.17%452.51K
800.91%409.49K
3,125.88%1.28M
-201.47%-587.68K
-224.36%-681.7K
Special income (charges)
-1,655.62%-762.19K
--0
-290.68%-71.32K
65.77%-477.22K
--0
-113.21%-43.41K
---415.55K
-125.00%-18.25K
-2,330.33%-1.39M
---1.8M
-Less:Other special charges
1,655.62%762.19K
----
290.68%71.32K
-65.77%477.22K
--0
113.21%43.41K
--415.55K
125.00%18.25K
2,330.33%1.39M
--1.8M
Income before tax
-111.08%-3.78M
7.01%-2.03M
-77.52%-1.73M
-31.96%-6.59M
39.65%-1.64M
-79.56%-1.79M
-265.72%-2.18M
-43.01%-975.1K
-333.64%-5M
-492.21%-2.72M
Income tax
Net income
-111.08%-3.78M
7.01%-2.03M
-77.52%-1.73M
-31.96%-6.59M
39.65%-1.64M
-79.56%-1.79M
-265.72%-2.18M
-43.01%-975.1K
-333.64%-5M
-492.21%-2.72M
Net income continuous Operations
-111.08%-3.78M
7.01%-2.03M
-77.52%-1.73M
-31.96%-6.59M
39.65%-1.64M
-79.56%-1.79M
-265.72%-2.18M
-43.01%-975.1K
-333.64%-5M
-492.21%-2.72M
Minority interest income
Net income attributable to the parent company
-111.08%-3.78M
7.01%-2.03M
-77.52%-1.73M
-31.96%-6.59M
39.65%-1.64M
-79.56%-1.79M
-265.72%-2.18M
-43.01%-975.1K
-333.64%-5M
-492.21%-2.72M
Preferred stock dividends
686.00%810.07K
2,769.24%739.06K
Other preferred stock dividends
0
941K
Net income attributable to common stockholders
-111.08%-3.78M
7.01%-2.03M
-77.52%-1.73M
2.29%-6.59M
62.70%-1.64M
-76.12%-1.79M
-250.60%-2.18M
-37.80%-975.1K
-437.54%-6.75M
-807.29%-4.4M
Basic earnings per share
-74.73%-1.59
21.95%-0.96
-45.61%-0.83
29.96%-3.53
74.69%-0.81
-13.75%-0.91
-227.80%-1.23
-33.75%-0.57
-566.71%-5.04
-995.97%-3.2
Diluted earnings per share
-74.73%-1.59
21.95%-0.96
-45.61%-0.83
29.96%-3.53
74.69%-0.81
-13.75%-0.91
-227.80%-1.23
-33.75%-0.57
-566.71%-5.04
-995.97%-3.2
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
--
--
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 90.82%3.05M1.16%1.48M-10.35%1.38M151.40%5.89M141.89%1.28M94.67%1.6M314.46%1.47M141.98%1.54M34.47%2.34M-46.35%530.34K
Selling and administrative expenses 198.03%1.65M33.70%836.92K28.21%798.74K83.22%2.38M7.64%572.38K263.43%553.97K132.05%625.97K81.90%622.98K79.77%1.3M-2.68%531.77K
-General and administrative expense 198.03%1.65M33.70%836.92K28.21%798.74K83.22%2.38M7.64%572.38K263.43%553.97K132.05%625.97K81.90%622.98K79.77%1.3M-2.68%531.77K
Research and development costs 34.00%1.4M-23.10%645.72K-36.42%586.1K235.80%3.52M49,574.16%710.45K56.22%1.05M901.17%839.67K211.51%921.8K2.50%1.05M-100.32%-1.44K
Operating profit -90.82%-3.05M-1.16%-1.48M10.35%-1.38M-151.40%-5.89M-141.89%-1.28M-94.67%-1.6M-314.46%-1.47M-141.98%-1.54M-34.47%-2.34M46.35%-530.34K
Net non-operating interest income expense 55.18%-270.15K41.55%-416.53K31.12%-476.06K-275.20%-2.52M-276.25%-509.65K2.55%-602.7K-284.76%-712.67K-342.75%-691.13K-1,220.41%-670.61K1,647.62%289.16K
Non-operating interest income -87.84%2.52K-26.52%14.16K28.55%21.45K--79.12K--22.4K--20.77K--19.27K--16.69K--0--0
Non-operating interest expense -56.26%272.68K-41.16%430.69K-17.57%497.52K418.21%2.49M211.06%532.05K0.81%623.47K295.16%731.94K286.65%603.57K846.48%480.7K-2,664.07%-479.07K
Total other finance cost -------------45.11%104.25K--0----------104.25K--189.91K----
Other net income (expense) -213.02%-462.37K-2,076.24%-132.05K-89.70%129.88K191.63%1.82M106.13%151.97K-7.34%409.09K89.61%-6.07K1,019.16%1.26M-408.84%-1.98M-551.93%-2.48M
Gain on sale of security -33.74%299.82K-132.25%-132.05K-84.27%201.19K490.19%2.29M122.29%151.97K301.17%452.51K800.91%409.49K3,125.88%1.28M-201.47%-587.68K-224.36%-681.7K
Special income (charges) -1,655.62%-762.19K--0-290.68%-71.32K65.77%-477.22K--0-113.21%-43.41K---415.55K-125.00%-18.25K-2,330.33%-1.39M---1.8M
-Less:Other special charges 1,655.62%762.19K----290.68%71.32K-65.77%477.22K--0113.21%43.41K--415.55K125.00%18.25K2,330.33%1.39M--1.8M
Income before tax -111.08%-3.78M7.01%-2.03M-77.52%-1.73M-31.96%-6.59M39.65%-1.64M-79.56%-1.79M-265.72%-2.18M-43.01%-975.1K-333.64%-5M-492.21%-2.72M
Income tax
Net income -111.08%-3.78M7.01%-2.03M-77.52%-1.73M-31.96%-6.59M39.65%-1.64M-79.56%-1.79M-265.72%-2.18M-43.01%-975.1K-333.64%-5M-492.21%-2.72M
Net income continuous Operations -111.08%-3.78M7.01%-2.03M-77.52%-1.73M-31.96%-6.59M39.65%-1.64M-79.56%-1.79M-265.72%-2.18M-43.01%-975.1K-333.64%-5M-492.21%-2.72M
Minority interest income
Net income attributable to the parent company -111.08%-3.78M7.01%-2.03M-77.52%-1.73M-31.96%-6.59M39.65%-1.64M-79.56%-1.79M-265.72%-2.18M-43.01%-975.1K-333.64%-5M-492.21%-2.72M
Preferred stock dividends 686.00%810.07K2,769.24%739.06K
Other preferred stock dividends 0941K
Net income attributable to common stockholders -111.08%-3.78M7.01%-2.03M-77.52%-1.73M2.29%-6.59M62.70%-1.64M-76.12%-1.79M-250.60%-2.18M-37.80%-975.1K-437.54%-6.75M-807.29%-4.4M
Basic earnings per share -74.73%-1.5921.95%-0.96-45.61%-0.8329.96%-3.5374.69%-0.81-13.75%-0.91-227.80%-1.23-33.75%-0.57-566.71%-5.04-995.97%-3.2
Diluted earnings per share -74.73%-1.5921.95%-0.96-45.61%-0.8329.96%-3.5374.69%-0.81-13.75%-0.91-227.80%-1.23-33.75%-0.57-566.71%-5.04-995.97%-3.2
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ----------------Unqualified Opinion--
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.